
SOPHiA GENETICS
SOPHiA GENETICS is a global leader in Data-Driven Medicine, committed to providing actionable insights through the integration of deep expertise in genomics, radiomics, and AI. By leveraging the power of AI and machine learning, SOPHiA GENETICS empowers healthcare institutions worldwide to make better and more informed decisions for their patients. Their platform enables clinicians, researchers, and healthcare organizations to analyze complex multimodal data, supporting more precise diagnosis and treatment.
The SOPHiA DDM™ platform is a universal and secure cloud-based software platform that combines innovative algorithms, clinical genomics, and real-world data to improve outcomes for patients and drive advancements in precision medicine.
SOPHiA GENETICS offers a range of CE-IVD (Conformité Européenne In Vitro Diagnostic) certified NGS (Next-Generation Sequencing) panels designed to provide comprehensive genomic insights for clinical use. These panels leverage the power of SOPHiA DDM™ (Data-Driven Medicine) technology to deliver accurate, reliable, and actionable results for healthcare professionals.
The CE-IVD NGS panels by SOPHiA GENETICS are meticulously developed to meet the stringent standards required for in vitro diagnostics within the European market, ensuring high quality and regulatory compliance. The panels support a wide array of applications, including oncology, rare and inherited disorders, and other complex diseases, providing clinicians with vital information to guide patient management, diagnosis, and personalized treatment strategies.
By integrating advanced AI and machine learning algorithms, SOPHiA GENETICS’ CE-IVD NGS panels enable precise variant detection and interpretation, supporting faster and more confident decision-making in clinical practice. These panels are designed for use in various settings, from routine diagnostics to research, enhancing the accuracy and efficiency of genetic testing workflows.
Key Features:
- Regulatory Compliance: CE-IVD certified for use in clinical diagnostics across Europe.
- High Sensitivity and Specificity: Engineered to provide accurate detection of genomic variants, including single nucleotide variants (SNVs), small insertions and deletions (indels), copy number variations (CNVs), and more.
- Multimodal Data Integration: Seamlessly integrates with the SOPHiA DDM™ platform for enhanced data analysis and interpretation.
- Broad Clinical Applications: Suitable for a wide range of genetic conditions, including oncology, hereditary diseases, and rare disorders.
- Scalability and Flexibility: Compatible with various sequencing technologies, offering flexibility to adapt to different laboratory needs.
Applications:
- Oncology: Comprehensive panels for solid tumors, hematological malignancies, and liquid biopsies, aiding in the identification of clinically relevant variants and guiding targeted therapy decisions.
- Inherited Diseases: Targeted panels for diagnosing rare and hereditary disorders, enabling early detection and management based on genetic predisposition.
- Cardiology and Neurology: Specialized panels focused on specific genetic conditions associated with cardiovascular and neurological diseases, providing crucial insights for patient care.
SOPHiA GENETICS’ CE-IVD NGS panels empower healthcare professionals to harness the full potential of genomic data, driving precision medicine and improving patient outcomes.
For more information, visit SOPHiA GENETICS website.